All In Biotech

Drug Trial Radar · NCT04659122

A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia

Phase 1b Open-label, Single Arm, Cohort Dose Escalation Study Evaluating the Safety, Tolerability, and Feasibility of Intervention With AT-100 (rhSP-D) in Intubated Patients Receiving Invasive Mechanical Ventilation With Severe COVID-19 Infection or Respiratory Failure Secondary to Severe Community Acquired Pneumonia

Last checked: Nov 19, 2026Latest source record: Aug 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

5

Actual

Start

Aug 17, 2021

Primary completion

Feb 23, 2023

Study completion Feb 23, 2023

Sponsor

Lead sponsor
Airway Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Dec 9, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if an investigational drug, AT-100, is safe and tolerated by adults who have severe corona virus disease 2019 (COVID-19) or respiratory failure secondary to severe community acquired pneumonia.

Conditions

  • COVID-19
  • Undefined

Interventions

  • AT-100Biological

    reconstituted AT-100 for intratracheal administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determining the highest-tolerated & safety-tested AT-100 doseTime frame: From time of initial AT-100 dosing until the end of the dosing period, up to 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Airway Therapeutics Investigational Site

    Cincinnati, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.